The world's second-most populous country this month recorded its highest monthly COVID-19 death toll since the pandemic began last year, accounting for just over a third of the overall total.
India reported 211,298 new infections on Thursday, the world's highest daily rise, but nearly half the daily infections it recorded earlier this month.
Over the weekend, the health ministry announced that 30% fewer vaccines had been received between January and April than expected. Queiroga said the Covax facility, an international cooperation to assist countries secure vaccines, had moved up the expected delivery of 2 million doses to May.
It added that it had secured a total 192 million doses of vaccines, including those from Moderna Inc, AstraZeneca PLC, Johnson & Johnson's and Novavax.
"The government has acquired COVID-19 vaccines large enough to vaccinate approximately 100 million people...(which) is double the entire population of South Korea," Health Minister Kwon Deok-cheol told a briefing.
In a Twitter post, the media office said this was in line with the latest international studies and guidelines on coronavirus vaccines.
It also said the DHA was cutting the time frame of vaccine eligibility for those who have previously contracted COVID-19 to 10 days from three months, provided the case was mild or asymptomatic.
Pfizer and its partner BioNTech agreed in November to supply Israel with an undisclosed number of COVID-19 vaccines and Israel's Finance Ministry has said it paid some 2.6 billion shekels ($785 million).
Israel's government is seeking to secure 36 million more Pfizer/BioNTech doses for use as booster shots or for children once they are eligible, but that hit a snag last week over political infighting.
Turkey has so far delivered 16.5 million vaccine doses nationwide, including more than 7 million people who have received a second dose of the shots developed by China's Sinovac Biotech.
A total of 2.8 million doses of the Pfizer vaccine have arrived in Turkey, with that number expected to reach 4.5 million in the coming days, Health Minister Fahrettin Koca said on Wednesday.
The shot was also 100% effective in preventing illness among trial participants in South Africa, where a new variant called B1351 is dominant, though the number of those participants was relatively small at 800.
While the new overall efficacy rate of 91.3% is lower than the 95% originally reported in November for its 44,000-person trial, a number of variants have become more prevalent around the world since then.
The doses to vaccinate two million people will be supplied in addition to the planned deliveries, to ease border movement and to tackle virus hotspots, the Commission said.
"To tackle aggressive variants of the virus and to improve the situation in hotspots, quick and decisive action is necessary," the president of the Commission, Ursula von der Leyen, said.
It is scheduled to receive 600,000 doses of Sputnik and another half a million doses of China's Sinopharm vaccine this month.
Orban said so far 264,530 Hungarians - healthcare workers and the most vulnerable elderly - have received at least one shot from the Pfizer and Moderna vaccines.
The Moderna COVID-19 vaccine is the second to be authorised for pandemic use in Singapore, after the Pfizer-BioNTech vaccine, which is already being rolled out in the city-state.
The document, which was prepared for a virtual meeting of Chancellor Angela Merkel with the 16 state premiers and representatives of pharmaceutical companies and the European Union later on Monday.
Castex and Health Minister Olivier Veran visited a health centre in Tarbes, southwestern France, on Saturday as part of the government's campaign to accelerate France's vaccine rollout.
US-based Moderna said on Monday it would produce at least 600 million doses of its COVID-19 vaccine in 2021, up by 100 million doses from its previous forecast.
France has been registering around 15,000 new infections per day, and on Friday confirmed the first case of a new coronavirus variant that recently emerged in Britain.
An airplane unloading containers with 4,875 doses of vaccines. The vaccines were later taken to the Institute of Virology, Vaccines and Sera, known as the "Torlak", in Belgrade.
"The immunisation, most probably, will start next week," Mirsad Djerlek, state secretary in the health ministry, told reporters in front of the "Torlak" Institute building.
While 28% of respondents in the survey by the Centre for Sociological Studies (CIS) said they would not take the vaccine immediately.
The EU drug regulator is expected to decide on Monday on approval for the vaccine developed by Pfizer and BioNTech after the shot was authorised in several countries.
Worries around the new virus strain also saw investors look past an agreement over a $900 billion fiscal aid package in the United States that will be set to vote on Monday.
Germany and France said they were set to begin inoculating their citizens with the Pfizer-BioNtech vaccine in the last week of December, once it is approved by the European Medicines Agency.